Newsfile Corp
23 Sept 2026, 20:36 UTC · 1h ago
ARS PHARMACEUTICALS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
Verdict
Headline takes no side. We score SPRY −0.80 across two claims — strongly bearish.
- Expected · SPRY
−0.80strongly bearish
−1 bearish0bullish +1More negative than 85% of ticker scores this week





